Brimonidine Tartrate Ophthalmic Solution, 0.2% (Westminster Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Brimonidine Tartrate Ophthalmic Solution, 0.2% drug offered from Westminster Pharmaceuticals, LLC. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Westminster Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Brimonidine Tartrate Ophthalmic Solution, 0.2% |
| SUBSTANCE NAME: | BRIMONIDINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-09-18 |
| END MARKETING DATE: | 0000-00-00 |
Brimonidine Tartrate Ophthalmic Solution, 0.2% HUMAN PRESCRIPTION DRUG Details:
| Item Description | Brimonidine Tartrate Ophthalmic Solution, 0.2% from Westminster Pharmaceuticals, LLC |
| LABELER NAME: | Westminster Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2015-09-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69367-109_20ede872-503c-398e-e054-00144ff8d46c |
| PRODUCT NDC: | 69367-109 |
| APPLICATION NUMBER: | ANDA091691 |
Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:
